Josep Creixell´s Biography

Josep Creixell was born in 1949 and is the CEO and founder of Tradebe. Josep holds an Economy degree and a Law degree from Barcelona University and an MBA from Columbia Business School.

Josep worked in McKinsey (Paris) and in Banco Industrial del Mediterraneo (Barcelona) before starting his entrepreneurial venture: Tradebe. Since 1978, Tradebe has been providing environmental services with specialized expertise in the management, treatment and recycling of waste, with particular emphasis on adding value for our customers.

Tradebe is now one of the leading companies in hazardous waste management in Spain, USA and UK. Its international presence is growing with subsidiaries in France, Turkey and Thailand.  Thanks to Tradebe´s continuing investment in new technologies and by making appropriate acquisitions, tied to improvements at our production facilities, its sales have grown from 37 million Euros in 1999 to 200 million Euros in 2009.  Tradebe employs more than 1100 people worldwide. In 2008, Tradebe managed more than 2 million Tonnes of waste, with 60% of this waste being recycled.

During the event, the Rafael del Pino Alumni had the opportunity to share with Dr. Prous his views on the current status of the biotech industry in Spain as well as the prospects for the biomedicine sector. Several experts of the pharmaceutical and biotech industries as well as MIT, Stanford, LBS, Wharton, Columbia and Chicago alumni attended the event.

Josep Prous Biography

After obtaining his PhD in Biochemistry , Dr Pous worked as researcher in the Pharmaceutical industry where he realized information about new drugs was scarce and spread among several publications. As a consequence of the discovery, the first product of Prous Science, the magazine “Drugs of Today” was created in order to inform about innovation in the development of new drugs.

Prous Science launched several successful products that incorporated the latest advances in information technologies such as Dailydrugnews.com life-science newsfeed and Integrity, the first integrated new drugs discovery and development website, with access to over 295.000 drugs and 100.000 patents.

With 350 employees, Prous Science is based in Barcelona and has expanded to US, Argentina and Japan. Prous Science has been awarded several prestigious international prizes including the European WWW Business Award by the European Commission. In 2007 Prous Science was acquired by Thomson Reuters

In 2000 Dr. Prous started a new endeavour in the Scientific Park of Barcelona, Prous Institute, a center for new drugs research using computational technologies for the treatment of cancer, diabetes or neurological conditions. Prous Institute is currently cooperating with the FDA in food and drugs toxicity prediction programs.

The Forum took place on 17 September, at “La Camarga” restaurant in Barcelona. David spoke about his entrepreneurial experience and about the future applications of the electronic National Identification Document (D.N.I.) on today’s and tomorrow’s society. Among those present were ex –scholars of the Rafael del Pino, “La Caixa“, Fulbright, March, Caja Madrid, Ramón Areces and Barriè de la Maza foundations, as well as post-graduate ex-alumni from MIT, Stanford University, London Business School, Wharton, Columbia and University of Chicago.

DESCRIPTION AND HISTORY OF TRACTIS

Tractis was founded in 2005 with the innovative concept of providing a legal system 100% online to the Internet nation; a fast and secure dispute resolution system that overcame the complexity and the slowness of the traditional legal systems. In order to achieve its objective, Tractis relies on European legislation about electronic signature (Directive 1999/93/EC), which grants the “qualified electronic signature” the same legal effects than a handwritten signature. Further, Tractis uses electronic National Identification Documents in intelligent card (e-ID) that are being issued by all governments of the European Union. In 2010 82% of the European population will live in a country with e-ID. After its launch in Spain, Belgium, Estonia, Finland, Portugal, Chile, Finland, Dominican Republic, Slovenia, India and Colombia, Austria becomes the eleventh country at a Worldwide level where Tractis has set up the signature with electronic certificate.

Tractis is already providing its services to Caixa Galicia and has recently won a contest with which it will distribute e-ID readers for a value of €1,750,000 among citizens before the end of the year.

Selected by Business 2.0 as one the 31 most promising start-ups outside the U.S, Tractis has won the Entrepreneurs Prize 2005 of the Everis Foundation and the Yahoo Web revelation 2007 prize under the Finance and Employment category.

During the event, that took place at the Círculo Ecuestre, Sanfeliu talked about his entrepreneurial experience, the evolution of the bio-pharmaceutical sector in the current Spanish society and the investments and private equity in the human health sector with a group of ex-scholars of the Rafael del Pino, “la Caixa“ , Fulbright, March, Caja Madrid, Ramón Areces and Barriè de la Maza foundations, as well as with ex-postgraduate alumni of MIT, Stanford University, London Business School, Wharton, Columbia y University of Chicago.

JOSEP SANFELIU’s BIOGRAPHY
Josep Sanfeliu, obtained his Law degree at the Pompeu Fabra University in Barcelona, did a LL.M at Michigan University in U.S.A. with a focus on patents, copyright and trademarks and later on, when his professional career had already started he graduated Global Executive MBA at IESE. He began his professional career at Cuatrecasas in the mergers and acquisitions and intellectual property departments working for the pharmaceutical and technological sectors. After working at KPMG and Eurohold Corporate in mergers and acquisitions and providing legal advice in private equity in the innovative sector (biotech, hospital oriented product, software, etc.) he joined the pharmaceutical sector at Almirall creating the Corporate Development Department as Financial Corporate Development Manager. After Almirall he initiated Ysios Capital Partners being at the same time in charge of the operative general management f a company of the the health sector Grupo SAR. During these years Josep, at a personal level, has worked with entrepreneurs not only as legal and financial advisor but also as co-founder partner and investor of companies such as Vlex, Netquest or Isuno in the innovation sector. Josep collaborates with IESE in the evaluation of projects in the health sciences and sanitary technology sectors and he is a member of Círculo de Economía and of Círculo Ecuestre.